A Study of Lemborexant in Chinese Participants With Insomnia Disorder

NCT04549168 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: Lemborexant
DRUG: Placebo

Sponsor

Eisai Co., Ltd.